News

Food and Drug Administration Gives The Go-Ahead For Marijuana Research In Alabama

sativex- growingfacility

Research into finding the true benefits of marijuana are starting to move forward, with the latest study being approved by the Food and Drug Administration.

According to an article in abc3340.com, the FDA has given the University of Alabama at Birmingham the green light to study the use of marijuana’s CBD compound and its ability to treat seizures.

Last year, parents of children with seizure disorders persuaded the Alabama Legislature to pass a bill authorizing UAB’s Department of Neurology to do a study of the marijuana derivative cannabidiol as a seizure treatment. A UAB spokesman said that the FDA has approved the study, but has requested modifications. A university review board will discuss the changes next month. The study will provide all participants with access to the oil, instead of giving placebos.

SOURCE

Show More

Richard Lowe

Richard Lowe is a 14-year veteran of the financial sector with licenses as a commodity broker (Series 3) and investment advisor representative (IAR Series 65). Along with a focus on raising capital for the firms he was employed with, he also wrote and edited much of the content published by them. He holds a BA in Journalism from the University of Massachusetts. He has been a longtime advocate for marijuana legalization due to the social injustices associated with marijuana prohibition and the strong potential for the medicinal benefits of cannabis.

Related Articles

Leave a Reply

Back to top button
Close
Close